4//SEC Filing
Mainolfi Nello 4
Accession 0001193125-25-323092
CIK 0001815442other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 6:07 PM ET
Size
6.6 KB
Accession
0001193125-25-323092
Insider Transaction Report
Form 4
Mainolfi Nello
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2025-12-17$38.53/sh+2,595$99,985→ 663,077 total - Exercise/Conversion
Stock Option (Right to Buy)
2025-12-17−2,595→ 272,505 totalExercise: $38.53Exp: 2032-03-01→ Common Stock (2,595 underlying)
Footnotes (1)
- [F1]The shares underlying this stock option are fully vested and exercisable.
Documents
Issuer
Kymera Therapeutics, Inc.
CIK 0001815442
Entity typeother
Related Parties
1- filerCIK 0001821189
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 6:07 PM ET
- Size
- 6.6 KB